Scientific Advisory Board Chairman of MMS Educates Professional Fiduciaries On Benefits In Using Medical Marijuana

Endocannabinoid molecules occur naturally in the human body and regulate multiple systems. Dr. Rabe referred to research which documents the pain-relieving, anti-oxidative, neuroprotective and anti-cancer effects of THC, CBD and other cannabinoids that make them potentially useful in the treatment of a variety of medical conditions.

“It is gratifying to see the strong level of interest in medicinal Cannabis shown by professional organizations, such as PFAC, in order to serve the best interest of their clients,” commented Dr. Rabe.

“Our work at Medical Marijuana Sciencesmay further broaden patient options with respect to cannabinoid-based therapies, particularly in the treatment of deadly diseases like pancreatic and brain cancers.Now that the MMS Scientific Advisory Board has successfully defined our initial lines of investigation, we anticipate moving forward with formal preclinical research soon,” he continued.

Dr. Rabe spoke about the future of a plant that has been used as a medicine for thousands of years, describing how it is Medical Marijuana Sciences’ mission to develop cannabinoid-based treatments utilizing Nuvilex’s Cell-in-a-Box technology as a bio-sustainable platform in order to provide targeted cancer chemotherapy.

To read more, visit  http://markets.financialcontent.com/stocks/news/read/27043417/Medical_Marijuana_Sciences’_Scientific_Advisory_Board_Chairman_Dr._Mark_L._Rabe_Educates_Professional_Fiduciaries_on_the_Benefits_of_Medical_Marijuana

Posted in: News

Comments are closed.